| RS2143422217 |
LOXHD1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2143422286 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143422990 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143424348 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143424506 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS2143424712 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143426682 |
JUP
|
Health Risk |
Pathogenic |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS2143427792 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143428858 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143429292 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143429307 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143430597 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2143432038 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2143432066 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143433058 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143435739 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143436505 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143436744 |
SALL1
|
Health Risk |
Likely pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS2143437310 |
SLC52A1
|
Health Risk |
Pathogenic |
— |
| RS2143437407 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143438540 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143438994 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2143439241 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143439415 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143439832 |
ZFHX3
|
Health Risk |
Likely pathogenic |
— |
| RS2143440696 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143440798 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143442272 |
FAM20A
|
Health Risk |
Pathogenic |
— |
| RS2143442678 |
SALL1
|
Health Risk |
Likely pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS2143446012 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS2143446286 |
SALL1
|
Health Risk |
Pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS2143447308 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia |
| RS2143447323 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143447351 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia |
| RS2143447451 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS2143447856 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143448019 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS2143448046 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS2143448771 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Hearing impairment |
| RS2143448859 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS2143449624 |
SALL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS2143449682 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS2143450145 |
SALL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS2143450333 |
SALL1
|
Health Risk |
Pathogenic |
— |
| RS2143450843 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143451028 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143451854 |
SALL1
|
Health Risk |
Pathogenic |
— |
| RS2143452148 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143452404 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143452445 |
SALL1
|
Health Risk |
Likely pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS2143456307 |
TUBG1
|
Health Risk |
Likely pathogenic |
— |
| RS2143456924 |
JUP
|
Health Risk |
Pathogenic |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS2143459144 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143459289 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS2143459811 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143460477 |
MED13
|
Health Risk |
Likely pathogenic |
— |
| RS2143461728 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143465205 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143465421 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143466709 |
SETD1A
|
Health Risk |
Pathogenic |
— |
| RS2143471373 |
MED13
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 61, Intellectual developmental disorder 61 |
| RS2143475577 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143477277 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143478260 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143480810 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143481657 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143481840 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143481938 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143484108 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143484371 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS2143485154 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143485431 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143485911 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143487816 |
BCAS3
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2143489377 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143489430 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143489510 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143491361 |
SETD1A
|
Health Risk |
Pathogenic |
— |
| RS2143491610 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143491920 |
SETD1A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2143492189 |
SRSF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual disability |
| RS2143492454 |
SETD1A
|
Health Risk |
Pathogenic |
— |
| RS2143495812 |
FAM20A
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS2143496821 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2143496899 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2143506473 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia |
| RS2143507207 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2143507418 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia 1 |
| RS2143509708 |
SETD1A
|
Health Risk |
Likely pathogenic |
Epilepsy, early-onset |
| RS2143514019 |
SETD1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2143524373 |
MYO9A
|
Health Risk |
Likely pathogenic |
Myasthenic syndrome, congenital |
| RS2143525603 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143525701 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143525756 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143526006 |
FAM20A
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS2143529644 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143529729 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143529990 |
FANCA
|
Health Risk |
Pathogenic |
Abnormality of blood and blood-forming tissues, Abnormality of blood and blood-forming tissues |
| RS2143530610 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2143530829 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |